Stereotaxis Stock Price, News & Analysis (OTCMKTS:STXS)

$0.80 0.01 (1.27 %)
(As of 12/11/2017 08:16 AM ET)
Previous Close$0.80
Today's Range$0.74 - $0.80
52-Week Range$0.47 - $1.10
Volume11,240 shs
Average Volume54,158 shs
Market Capitalization$18.24 million
P/E Ratio3.81
Dividend YieldN/A
Beta3.34

About Stereotaxis (OTCMKTS:STXS)

Stereotaxis, Inc. is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab. The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information. The Company's Epoch solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The Niobe ES remote magnetic navigation system includes the Navigant software user interface and the QuikCAS catheter advancement system. The Vdrive robotic navigation system with Niobe ES magnetic navigation system provides navigation and stability for diagnostic and ablation devices.

Receive STXS News and Ratings via Email

Sign-up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:STXS
CUSIPN/A
Phone314-678-6100

Debt

Debt-to-Equity RatioN/A
Current Ratio0.44%
Quick Ratio0.29%

Price-To-Earnings

Trailing P/E Ratio3.81
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$32.16 million
Price / Sales0.57
Cash FlowN/A
Price / CashN/A
Book Value($0.98) per share
Price / Book-0.82

Profitability

Trailing EPS$0.02
Net Income$-5,280,000.00
Net Margins7.12%
Return on Equity-30.95%
Return on Assets36.99%

Miscellaneous

Employees120
Outstanding Shares22,800,000

Stereotaxis (OTCMKTS:STXS) Frequently Asked Questions

What is Stereotaxis' stock symbol?

Stereotaxis trades on the OTCMKTS under the ticker symbol "STXS."

How were Stereotaxis' earnings last quarter?

Stereotaxis Inc (OTCMKTS:STXS) posted its quarterly earnings data on Monday, May, 9th. The medical equipment provider reported ($0.11) EPS for the quarter. The medical equipment provider had revenue of $8.60 million for the quarter, compared to the consensus estimate of $9.50 million. Stereotaxis had a negative return on equity of 30.95% and a net margin of 7.12%. View Stereotaxis' Earnings History.

When will Stereotaxis make its next earnings announcement?

Stereotaxis is scheduled to release their next quarterly earnings announcement on Thursday, March, 15th 2018. View Earnings Estimates for Stereotaxis.

Who are some of Stereotaxis' key competitors?

Who are Stereotaxis' key executives?

Stereotaxis' management team includes the folowing people:

  • David Fischel, Chairman of the Board, Acting Chief Executive Officer (Age 30)
  • Martin C. Stammer, Chief Financial Officer (Age 36)
  • Karen W. Duros, Senior Vice President, General Counsel, Secretary (Age 62)
  • David A. Giffin, Vice President - Human Resources (Age 68)
  • Paul A. Brathwaite Ph.D., Vice President - Research & Development (Age 47)
  • Joseph E. Kiani, Director (Age 52)
  • Arun Swarup Menawat Ph.D., Director (Age 62)
  • David W. Benfer, Independent Director (Age 70)
  • Nathan Fischel M.D., Independent Director (Age 61)
  • Robert J. Messey, Independent Director (Age 71)

How do I buy Stereotaxis stock?

Shares of Stereotaxis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Stereotaxis' stock price today?

One share of Stereotaxis stock can currently be purchased for approximately $0.80.

How big of a company is Stereotaxis?

Stereotaxis has a market capitalization of $18.24 million and generates $32.16 million in revenue each year. The medical equipment provider earns $-5,280,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Stereotaxis employs 120 workers across the globe.

How can I contact Stereotaxis?

Stereotaxis' mailing address is 4320 Forest Park Avenue Suite 100, ST.LOUIS MO, 63108. The medical equipment provider can be reached via phone at 314-678-6100 or via email at [email protected]


MarketBeat Community Rating for Stereotaxis (STXS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  76
MarketBeat's community ratings are surveys of what our community members think about Stereotaxis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Stereotaxis (OTCMKTS:STXS) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Stereotaxis (OTCMKTS:STXS) Earnings History and Estimates Chart

Earnings by Quarter for Stereotaxis (OTCMKTS:STXS)

Stereotaxis (OTCMKTS STXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/15/2018        
8/10/2017Q2 2017($0.02)$8.47 millionViewN/AView Earnings Details
5/8/2017Q1 2017$0.01$6.98 millionViewListenView Earnings Details
5/9/2016Q1($0.11)$9.50 million$8.60 millionViewListenView Earnings Details
2/22/2016Q4($0.10)$9.80 million$9.20 millionViewListenView Earnings Details
11/3/2015Q3($0.05)$8.90 million$9.30 millionViewListenView Earnings Details
8/4/2015Q215($0.12)$120.60 million$9.66 millionViewN/AView Earnings Details
5/6/2015Q115($0.15)$8.40 million$9.50 millionViewListenView Earnings Details
2/25/2015Q414$0.04$9.10 million$9.80 millionViewListenView Earnings Details
5/6/2014Q1($0.16)$8.40 million$8.40 millionViewListenView Earnings Details
2/25/2014Q4($0.19)$12.20 million$9.10 millionViewListenView Earnings Details
11/12/2013Q3($0.26)$9.70 million$10.80 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.59)($0.37)$10.80 million$9.70 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.50)($0.61)$12.00 million$8.40 millionViewListenView Earnings Details
11/5/2012Q312($0.72)($0.33)$10.30 million$11.60 millionViewN/AView Earnings Details
3/5/2012($0.14)($0.10)ViewN/AView Earnings Details
11/7/2011($0.16)($0.13)ViewN/AView Earnings Details
8/8/2011($0.12)($0.18)ViewN/AView Earnings Details
5/2/2011($0.13)($0.17)ViewN/AView Earnings Details
2/28/2011($0.11)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Stereotaxis (OTCMKTS:STXS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Stereotaxis (OTCMKTS:STXS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Stereotaxis (OTCMKTS STXS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 22.05%
Institutional Ownership Percentage: 6.08%
Insider Trades by Quarter for Stereotaxis (OTCMKTS:STXS)

Stereotaxis (OTCMKTS STXS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2015Fred A MiddletonDirectorSell26,064$1.57$40,920.48View SEC Filing  
6/12/2015Fred A MiddletonDirectorSell16,273$1.61$26,199.53View SEC Filing  
6/9/2015Fred A MiddletonDirectorSell106,876$1.65$176,345.40View SEC Filing  
3/13/2015David BenferDirectorBuy3,000$1.95$5,850.00View SEC Filing  
12/12/2014William C Mills IIICEOBuy10,000$1.45$14,500.00View SEC Filing  
12/9/2014Fred A MiddletonDirectorSell8,551$1.51$12,912.01View SEC Filing  
12/5/2014William C Mills IIICEOBuy10,000$1.43$14,300.00View SEC Filing  
12/3/2014Fred A MiddletonDirectorSell15,809$1.59$25,136.31View SEC Filing  
8/11/2014William C Mills IIICEOBuy10,000$2.75$27,500.00View SEC Filing  
3/13/2014Fred A MiddletonDirectorSell24,302$4.21$102,311.42View SEC Filing  
8/23/2013Fred A MiddletonDirectorSell14,600$3.67$53,582.00View SEC Filing  
8/20/2013Christopher D AlafiMajor ShareholderSell261,241$3.74$977,041.34View SEC Filing  
8/7/2013Fred A MiddletonDirectorSell78,974$10.13$800,006.62View SEC Filing  
11/30/2012Fred A MiddletonDirectorBuy24,360$1.53$37,270.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Stereotaxis (OTCMKTS STXS) News Headlines

Source:

SEC Filings

Stereotaxis (OTCMKTS:STXS) SEC Filings

DateFilerForm TypeView

Social Media

Financials

Stereotaxis (OTCMKTS:STXS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Stereotaxis (OTCMKTS STXS) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.